Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System
暂无分享,去创建一个
[1] V. L. Schermer,et al. Book Review: Ruptures in the American Psyche: Containing Destructive Populism in Perilous Times , 2022, Group Analysis.
[2] D. Hampson,et al. The calcium‐sensing receptor and integrins modulate cerebellar granule cell precursor differentiation and migration , 2016, Developmental neurobiology.
[3] J. Mora,et al. Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens , 2016 .
[4] W. Janssen,et al. c-Myc-dependent transcriptional regulation of cell cycle and nucleosomal histones during oligodendrocyte differentiation , 2014, Neuroscience.
[5] A. Fernandes,et al. Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. , 2014, Biochimica et biophysica acta.
[6] W. Weiss,et al. The prenatal origins of cancer , 2014, Nature Reviews Cancer.
[7] K. Kalil,et al. Branch management: mechanisms of axon branching in the developing vertebrate CNS , 2013, Nature Reviews Neuroscience.
[8] William A Weiss,et al. Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.
[9] F. Bruggeman,et al. Calcium sensing receptor signalling in physiology and cancer. , 2013, Biochimica et biophysica acta.
[10] Andrew P. Feinberg,et al. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host , 2013, Nature Reviews Cancer.
[11] M. Ruat,et al. Roles of the calcium sensing receptor in the central nervous system. , 2013, Best practice & research. Clinical endocrinology & metabolism.
[12] Michael A. Dyer,et al. Neuroblastoma: developmental biology, cancer genomics and immunotherapy , 2013, Nature Reviews Cancer.
[13] D. Miao,et al. Calcium Sensing Receptor Absence Delays Postnatal Brain Development via Direct and Indirect Mechanisms , 2013, Molecular Neurobiology.
[14] J. Mora,et al. Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma , 2013, PloS one.
[15] J. Jui,et al. Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. , 2013, Cell reports.
[16] J. Mora,et al. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. , 2012, Carcinogenesis.
[17] Stanley He,et al. MYCN and the epigenome , 2013, Front. Oncol..
[18] Steven J. M. Jones,et al. The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.
[19] M. Bronner,et al. Development and evolution of the neural crest: an overview. , 2012, Developmental biology.
[20] Shazia Tanvir,et al. Effects of WCDMA modulated TF exposure on the structure and function of the human , 2012 .
[21] D. Zwijnenburg,et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.
[22] D. Riccardi,et al. The calcium-sensing receptor beyond extracellular calcium homeostasis: conception, development, adult physiology, and disease. , 2012, Annual review of physiology.
[23] S. Påhlman,et al. Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage. , 2011, Seminars in cancer biology.
[24] A. Xiao,et al. Epigenetic regulation in neural crest development. , 2011, Birth defects research. Part A, Clinical and molecular teratology.
[25] R. Stallings,et al. Co-Localization of the Oncogenic Transcription Factor MYCN and the DNA Methyl Binding Protein MeCP2 at Genomic Sites in Neuroblastoma , 2011, PloS one.
[26] R. Morgan,et al. Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. , 2011, Cancer research.
[27] A. Bird,et al. CpG islands and the regulation of transcription. , 2011, Genes & development.
[28] M. Maio,et al. The biology of cancer testis antigens: Putative function, regulation and therapeutic potential , 2011, Molecular oncology.
[29] G. Raschellà,et al. Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop , 2010, Oncotarget.
[30] S. Bandyopadhyay,et al. Diverse roles of extracellular calcium‐sensing receptor in the central nervous system , 2010, Journal of neuroscience research.
[31] J. Maris. Recent advances in neuroblastoma. , 2010, The New England journal of medicine.
[32] Y. Gotoh,et al. Epigenetic control of neural precursor cell fate during development , 2010, Nature Reviews Neuroscience.
[33] W. Weiss,et al. Myc proteins as therapeutic targets , 2010, Oncogene.
[34] Raymond L. Stallings,et al. Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation , 2009, PloS one.
[35] P. Cartron,et al. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation , 2009, Epigenetics.
[36] J. Mora,et al. The calcium‐sensing receptor and parathyroid hormone‐related protein are expressed in differentiated, favorable neuroblastic tumors , 2009, Cancer.
[37] Gudrun Schleiermacher,et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma , 2008, Nature.
[38] S. Bandyopadhyay,et al. Calcium receptor expression and function in oligodendrocyte commitment and lineage progression: Potential impact on reduced myelin basic protein in CaR‐null mice , 2008, Journal of neuroscience research.
[39] A. Davies,et al. Regulation of axonal and dendritic growth by the extracellular calcium-sensing receptor , 2008, Nature Neuroscience.
[40] A. Spiegel,et al. Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators , 2007, Journal of cellular and molecular medicine.
[41] S. Giannini,et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. , 2007, Kidney international.
[42] K. Siminovitch,et al. Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics. , 2007, Clinical biochemistry.
[43] U. Armato,et al. Roles of Ca2+ and the Ca2+‐sensing receptor (CASR) in the expression of inducible NOS (nitric oxide synthase)‐2 and its BH4 (tetrahydrobiopterin)‐dependent activation in cytokine‐stimulated adult human astrocytes , 2005, Journal of cellular biochemistry.
[44] Antonio Porro,et al. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] G. Perilongo,et al. Childhood solid tumours: a developmental disorder , 2005, Nature Reviews Cancer.
[46] L. Muscarella,et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. , 2004, The Journal of clinical endocrinology and metabolism.
[47] M. Mori,et al. GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] W. Gerald,et al. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. , 2004, Journal of the National Cancer Institute.
[49] H. Shimada,et al. The International Neuroblastoma Pathology Classification. , 2003, Pathologica.
[50] A. Graham,et al. The neural crest , 2003, Current Biology.
[51] G. Brodeur. Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.
[52] R. Eisenman,et al. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. , 2002, Genes & development.
[53] C. Eng,et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours , 2001, Oncogene.
[54] D. Stram,et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors , 2001, Cancer.
[55] A. Iavarone,et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.
[56] E. Brown,et al. Regulation of secretion of PTHrP by Ca(2+)-sensing receptor in human astrocytes, astrocytomas, and meningiomas. , 2000, American journal of physiology. Cell physiology.
[57] J. Stinnakre,et al. Developmental and adult expression of rat calcium‐sensing receptor transcripts in neurons and oligodendrocytes , 2000, The European journal of neuroscience.
[58] E. Brown,et al. Extracellular calcium-sensing receptor induces cellular proliferation and activation of a nonselective cation channel in U373 human astrocytoma cells , 1999, Brain Research.
[59] K K Matthay,et al. The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.
[60] F. Speleman,et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. , 1999, The New England journal of medicine.
[61] E. Brown,et al. The Extracellular Calcium‐Sensing Receptor Is Expressed in Rat Microglia and Modulates an Outward K+ Channel , 1999, Journal of neurochemistry.
[62] Hiroyuki Tanaka,et al. A986S polymorphism of calcium-sensing receptor , 1999, The Lancet.
[63] G. Hawker,et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations , 1999, The Lancet.
[64] E. Brown,et al. Extracellular calcium‐sensing receptor in rat oligodendrocytes: Expression and potential role in regulation of cellular proliferation and an outward K+ channel , 1998, Glia.
[65] M F Balandrin,et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] J. A. Weston,et al. Timing and pattern of cell fate restrictions in the neural crest lineage. , 1997, Development.
[67] E. Brown,et al. Calcium-sensing receptor in the rat hippocampus: a developmental study. , 1997, Brain research. Developmental brain research.
[68] E. Brown,et al. Localization of calcium receptor mRNA in the adult rat central nervous system by in situ hybridization , 1997, Brain Research.
[69] P. Ambros,et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. , 1996, The New England journal of medicine.
[70] M. Leppert,et al. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. , 1996, The Journal of clinical endocrinology and metabolism.
[71] J. Herman,et al. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.
[72] J. Seidman,et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1995, Nature Genetics.
[73] S. Snyder,et al. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[74] M. Hediger,et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid , 1993, Nature.
[75] A. Cantor,et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. , 1993, The New England journal of medicine.
[76] D. Anderson,et al. Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[77] David J. Anderson,et al. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids , 1986, Cell.
[78] H. Varmus,et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.
[79] J. Trent,et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.
[80] H. B. Marsden,et al. Histologic patterns of neuroblastoma related to prognosis and clinical staging , 1974, Cancer.
[81] Ruth Lundeen Memmler,et al. Structure and function of the human body , 1970 .
[82] M. V. van Noesel,et al. Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest. , 2012, The Lancet. Oncology.
[83] L. Muscarella,et al. Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. , 2007, The Journal of clinical endocrinology and metabolism.
[84] E. Brown,et al. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. , 1997, The Journal of clinical investigation.
[85] F. Alt,et al. Differential expression of myc family genes during murine development , 1986, Nature.